Legislators
Bills
Statements
Lobbying
Travel
Searching...- Bills
- H.R.5894
H.R.5894: Transparency in Prescription Drug Advertising Act
About This Bill
- This bill was introduced in the 116th Congress
- This bill is primarily about health
- Introduced Feb. 13, 2020
- Latest Major Action Feb. 13, 2020
Bill Sponsor
Bill Cosponsors
3 (All Democrats)
Bill Version
- Introduced in House - Feb. 13, 2020
Bill Summary
Transparency in Prescription Drug Advertising Act This bill requires that the list prices of drugs be included, as appropriate, in advertising for such drugs and directs the Department of Health and Human Services to issue department-wide guidance to that effect that is consistent with regulations issued by the Centers for Medicare & Medicaid Services (CMS) regarding drug price transparency. On May 10, 2019, the CMS issued a final rule titled...
(Source: Library of Congress)
Bill Actions
| Date | Description |
|---|---|
| Feb. 13, 2020 |
Referred to the House Committee on Energy and Commerce.
|
| Feb. 13, 2020 |
Introduced in the House by Sharice Davids (D-Kan.) |